← Leaderboards
Jeffrey R. Bender
Yale University
$22,395,373
Attributed
$24,282,688
Total exposure
12
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$24,282,688 · 12
By mechanism
R01$11,075,077 · 4
T32$9,032,849 · 1
P01$2,233,900 · 2
R21$1,324,612 · 3
R56$371,250 · 1
R43$245,000 · 1
Top collaborators
- Hyung Joon Chun10 shared
- Vinod Satisch Ramgolam1 shared
Most similar at Yale University
Same institution · by research overlap
- Karl Leonard Insogna$20,488,083
- Jordan S Pober$30,894,969
Others in their field
Top investigators on “Blood Vessels”
- Sonia M Thomas · Research Triangle Institute$353,402,726
- Tracy L Nolen · Research Triangle Institute$353,402,726
- Charles Decarli · University Of California At Davis$66,498,201
- Josef Coresh · New York University School Of Medicine$63,693,760
- Sterling C Johnson · St. Joseph'S Hospital And Medical Center$62,000,770
- Robert P Kimberly · University Of Alabama At Birmingham$56,093,149
Research focus
Blood VesselsMolecularMediatingIn VitroIn VivoResponseGene ExpressionImmuneProductionIntegrinsCellsPlayChronicMessenger RnaLaboratory MouseProteinsSiteSignal TransductionInjuryTissuesUntranslated RegionsGenerationsEndothelial CellsHuman Tissue
Grant awards (73)
Vascular Training Grant$141,343
T32 · FY2025 · HL · contact PI
Vascular Training Grant$296,794
T32 · FY2024 · HL · contact PI
Immune cell skewing with RNA target site oligonucleotides to promote vascular smooth muscle cell homeostasis$209,375
R21 · FY2024 · AI · contact PI
Vascular Training Grant$443,652
T32 · FY2023 · HL · contact PI
Immune cell skewing with RNA target site oligonucleotides to promote vascular smooth muscle cell homeostasis$251,250
R21 · FY2023 · AI · contact PI
IL-17A mRNA-targeted oligonucleotide therapeutics in Idiopathic Pulmonary Fibrosis (IPF)$245,000
R43 · FY2023 · HL
Vascular Training Grant$582,512
T32 · FY2022 · HL · contact PI
microRNA target site RNA-directed oligonucleotide topical therapeutics in psoriasis$182,408
R21 · FY2022 · AR · contact PI
Vascular Training Grant$552,721
T32 · FY2021 · HL · contact PI
microRNA target site RNA-directed oligonucleotide topical therapeutics in psoriasis$221,100
R21 · FY2021 · AR · contact PI
Competitive macrophage microRNA-RNA binding protein interactions in wound repair$322,438
R01 · FY2020 · GM · contact PI
Vascular Research Training$103,579
T32 · FY2020 · HL · contact PI
Competitive macrophage microRNA-RNA binding protein interactions in wound repair$322,438
R01 · FY2019 · GM · contact PI
Vascular Research Training$559,569
T32 · FY2018 · HL · contact PI
Competitive macrophage microRNA-RNA binding protein interactions in wound repair$322,438
R01 · FY2018 · GM · contact PI
Vascular Research Training$359,358
T32 · FY2017 · HL · contact PI
Competitive macrophage microRNA-RNA binding protein interactions in wound repair$322,438
R01 · FY2017 · GM · contact PI
Modulation neuroinflammation through interference of cooperative microRNA-RNA-binding protein interactions$167,500
R21 · FY2017 · AI · contact PI
Vascular Research Training$3,424
T32 · FY2017 · HL · contact PI
Vascular Research Training$486,678
T32 · FY2016 · HL · contact PI
Modulation neuroinflammation through interference of cooperative microRNA-RNA-binding protein interactions$292,979
R21 · FY2016 · AI · contact PI
Vascular Research Training$299,432
T32 · FY2015 · HL · contact PI
Vascular Research Training$353,060
T32 · FY2014 · HL · contact PI
Vascular Research Training$458,850
T32 · FY2013 · HL · contact PI
Vascular Research Training$463,477
T32 · FY2012 · HL · contact PI
Molecular Models of Immune-mediated Vascular Injury$409,613
R01 · FY2012 · HL · contact PI
Molecular Models of Immune-mediated Vascular Injury$413,750
R01 · FY2011 · HL · contact PI
Molecular Models of Estrogen-induced Vascular Protection$372,375
R01 · FY2011 · HL · contact PI
Vascular Research Training$340,540
T32 · FY2011 · HL · contact PI
Molecular Models of Immune-mediated Vascular Injury$413,750
R01 · FY2010 · HL · contact PI
An IFN-y-Integrin-Growth Factor Axis in GA Biomarker Development$387,265
P01 · FY2010 · HL · contact PI
Molecular Models of Estrogen-induced Vascular Protection$372,375
R01 · FY2010 · HL · contact PI
Vascular Research Training$204,395
T32 · FY2010 · HL · contact PI
Vascular Research Training$448,691
T32 · FY2009 · HL · contact PI
Molecular Models of Immune-mediated Vascular Injury$413,750
R01 · FY2009 · HL · contact PI
An IFN-y-Integrin-Growth Factor Axis in GA Biomarker Development$379,926
P01 · FY2009 · HL · contact PI
Molecular Models of Estrogen-induced Vascular Protection$372,375
R01 · FY2009 · HL · contact PI
Vascular Research Training$446,877
T32 · FY2008 · HL · contact PI
Molecular Models of Immune-mediated Vascular Injury$413,645
R01 · FY2008 · HL · contact PI
Molecular Models of Estrogen-induced Vascular Protection$372,094
R01 · FY2008 · HL · contact PI
An IFN-y-Integrin-Growth Factor Axis in GA Biomarker Development$364,289
P01 · FY2008 · HL · contact PI
Vascular Research Training$454,251
T32 · FY2007 · HL · contact PI
Molecular Models of Estrogen-induced Vascular Protection$371,250
R56 · FY2007 · HL · contact PI
An IFN-y-Integrin-Growth Factor Axis in GA Biomarker Development$367,349
P01 · FY2007 · HL · contact PI
Molecular Models of Immune-mediated Vascular Injury$411,119
R01 · FY2006 · HL · contact PI
Vascular Research Training$406,642
T32 · FY2006 · HL · contact PI
An IFN-y-Integrin-Growth Factor Axis in GA Biomarker Development$363,680
P01 · FY2006 · HL · contact PI
Molecular Models of Estrogen-induced Vascular Protection$319,316
R01 · FY2006 · HL · contact PI
Molecular Models of Immune-mediated Vascular Injury$408,750
R01 · FY2005 · HL
VASCULAR RESEARCH TRAINING$372,433
T32 · FY2005 · HL
Molecular Models of Estrogen-induced Vascular Protection$327,000
R01 · FY2005 · HL
Imaging DTH, IFN gamma responses &GA in human arteries$193,924
P01 · FY2005 · HL
Molecular Models of Immune-mediated Vascular Injury$36,788
R01 · FY2005 · HL
Molecular Models of Immune-mediated Vascular Injury$408,750
R01 · FY2004 · HL
Vascular Research Training$387,621
T32 · FY2004 · HL
Molecular Models of Estrogen-induced Vascular Protection$327,000
R01 · FY2004 · HL
VASCULAR RESEARCH TRAINING$435,295
T32 · FY2003 · HL
Molecular Models of Immune-mediated Vascular Injury$408,750
R01 · FY2003 · HL
CONTACT DEPENDENT ENDOTHELIAL ACTIVATION BY NK CELLS$331,972
R01 · FY2003 · HL
Molecular Models of Estrogen-induced Vascular Protection$327,000
R01 · FY2003 · HL
Molecular Models of Immune-mediated Vascular Injury$408,750
R01 · FY2002 · HL
CONTACT DEPENDENT ENDOTHELIAL ACTIVATION BY NK CELLS$324,248
R01 · FY2002 · HL
MOLECULAR MODELS OF ESTROGEN INDUCED VASCULAR PROTECTION$290,819
R01 · FY2002 · HL
VASCULAR RESEARCH TRAINING$283,322
T32 · FY2002 · HL
Imaging DTH, IFN gamma responses &GA in human arteries$177,467
P01 · FY2002 · HL
MOLECULAR MODELS OF IMMUNE MEDIATED VASCULAR INJURY$359,963
R01 · FY2001 · HL
CONTACT DEPENDENT ENDOTHELIAL ACTIVATION BY NK CELLS$316,747
R01 · FY2001 · HL
MOLECULAR MODELS OF ESTROGEN INDUCED VASCULAR PROTECTION$284,668
R01 · FY2001 · HL
Imaging DTH, IFN gamma responses &GA in human arteries$0
P01 · FY2001 · HL
MOLECULAR MODELS OF IMMUNE MEDIATED VASCULAR INJURY$351,793
R01 · FY2000 · HL
CONTACT DEPENDENT ENDOTHELIAL ACTIVATION BY NK CELLS$309,465
R01 · FY2000 · HL
MOLECULAR MODELS OF ESTROGEN INDUCED VASCULAR PROTECTION$278,700
R01 · FY2000 · HL
VASCULAR RESEARCH TRAINING$148,333
T32 · FY2000 · HL